fingolimod hydrochloride
SpainDrugs containing this active substance
-
It is used in adults and in children and adolescents (from 10 years of age and older) to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or whose disease progresses rapidly.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Accord Healthcare S.L.U.
-
It is used in adults and in children and adolescents aged 10 years and older to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or whose disease progresses severely. It helps reduce the number of relapses and the progression of physical disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Aurovitas Spain, S.A.U.
-
It is used in adults and in children and adolescents aged 10 years and older to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or who experience rapid disease progression. It helps reduce the number of relapses and the progression of physical disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Reddy Pharma Iberia S.A.
-
It is used in adults and in children and adolescents aged 10 years or older (weighing more than 40 kg) to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or whose disease progresses rapidly. It helps reduce the number of relapses and the progression of physical disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Glenmark Arzneimittel Gmbh
-
It is used in adults, children, and adolescents (from 10 years of age onwards) to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or whose disease progresses rapidly. It helps to reduce the number of relapses and the progression of physical disabilities.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Kern Pharma S.L.
-
It is used in adults and in children and adolescents aged 10 years and older to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or whose disease progresses rapidly. It helps to reduce the number of relapses and the progression of physical disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Krka D.D. Novo Mesto
-
It is used in adults, adolescents, and children aged 10 years and older (with a body weight over 40 kg) to treat relapsing-remitting multiple sclerosis, particularly in patients who do not respond to other treatments or who have a severe form of the disease. It helps reduce the number of relapses and the progression of physical disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Laboratorio Stada S.L.
-
It is used in adults, children, and adolescents (from 10 years of age and weighing more than 40 kg) to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or whose disease progresses severely. It helps reduce the number of relapses and the progression of physical disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Sun Pharmaceutical Industries (Europe) B.V.
-
It is used in adults and in children and adolescents (from 10 years of age and older) to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or whose disease progresses severely. It helps to reduce the number of relapses and the progression of physical disabilities.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,25 mg Manufacturer: Tarbis Farma S.L.
-
It is used in adults and in children and adolescents (from 10 years of age and older) to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or whose disease progresses severely. It helps reduce the number of relapses and the progression of physical disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Tarbis Farma S.L.
-
It is used in adults and in children and adolescents (from 10 years of age and older) to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or whose disease progresses rapidly. It helps reduce the number of relapses and the rate of physical disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Viatris Pharmaceuticals S.L.
-
It is used in adults and in children and adolescents (from 10 years of age and weighing more than 40 kg) to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or whose disease progresses rapidly. It helps to reduce the number of relapses and the rate of physical disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Zentiva K.S.
-
It is used in adults and in children and adolescents aged 10 years and older to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or whose disease progresses rapidly. It helps to reduce relapses and the progression of physical disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,28 mg Manufacturer: Teva Pharma S.L.U.
-
It is used in adults and in children and adolescents (from 10 years of age onwards) to treat relapsing-remitting multiple sclerosis, especially in patients who do not respond to other treatments or who experience rapid disease progression. It helps to reduce relapses and the progression of physical disability.
Form: capsules, hard
Active substance Dosage fingolimod hydrochloride 0,56 mg Manufacturer: Teva Pharma S.L.U.